Meeting
2023 ASCO Genitourinary Cancers Symposium
Relapse-free and overall survival in patients with non-seminomatous testicular germ cell tumours with teratoma-free primaries.
Authors
Pia Paffenholz
Department of Urology, University Hospital of Cologne, Cologne, Germany
Pia Paffenholz , Georg Landwehr , Christoph Alexander Seidel , Annika Poch , Carsten Bokemeyer , Richard Cathomas , Pailin Pongratanakul , Andreas Hiester , Peter Albers , Martin Pichler , Susanne Krege , Isabella Syring , Julia Heinzelbecker , Tim Nestler , David Pfister , Axel Heidenreich
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer; Adrenal, Penile, Urethral and Testicular Cancers
Track
Renal Cell Cancer,Adrenal Cancer,Penile Cancer,Testicular Cancer,Urethral Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 421)
DOI
10.1200/JCO.2023.41.6_suppl.421
Abstract #
421
Poster Bd #
M3
Abstract Disclosures
Similar Posters
Poster
2019 Genitourinary Cancers Symposium
Clinical features and outcomes of secondary somatic malignancy (SSM) associated with primary mediastinal nonseminomatous germ cell tumors (PM-NSGCT).
First Author: Lucas W. Dean
Poster
2024 ASCO Annual Meeting
Management of relapsed stage I nonseminomatous germ-cell tumor with retroperitoneal only relapse.
First Author: Ahmed Bilal Khalid
Poster
2024 ASCO Annual Meeting
High dose chemotherapy in male patients with germ cell cancer: A population-based study by the SWENOTECA group.
First Author: Anna Jansson
Poster
2024 ASCO Annual Meeting
Primary intracranial germ cell tumors in adolescents and adults: Results of an international, multicenter, retrospective cohort study.
First Author: Stefanie Zschaebitz